| Literature DB >> 31166467 |
Elisa Maria Michels Krüger1, Fernanda Sinkos1, Julia Feldmann Uhry1, Julio Cesar Bezerra De Boni1, Cristina Terumi Okamoto1, Kátia Sheylla Malta Purin1, Renato Nisihara1.
Abstract
OBJECTIVE: To evaluate the prevalence of neonatal dermatoses in the early neonatal period and to associate them with neonatal, demographic and obstetric variables.Entities:
Mesh:
Year: 2019 PMID: 31166467 PMCID: PMC6868561 DOI: 10.1590/1984-0462/;2019;37;3;00012
Source DB: PubMed Journal: Rev Paul Pediatr ISSN: 0103-0582
Figure 1Neonatal dermatoses observed in the studied group.
Distribution of neonatal dermatoses according to the categories identified in the 350 newborns.
| Dermatosis by category | n | Frequency (%) |
|---|---|---|
| General | ||
| Sebaceous Hyperplasia | 233 | 66.6 |
| Physiological flaking | 140 | 40 |
| Fluff | 149 | 42.6 |
| Vernix caseosa | 91 | 26 |
| Crystalline miliaria | 89 | 25.4 |
| Toxic erythema | 18 | 5.1 |
| Neonatal cephalic pustulosis | 7 | 2 |
| Local | ||
| Diaper erythmea | 19 | 5.4 |
| Seborrheic dermatitis | 1 | 0.3 |
| Vascular | ||
| Salmon patches | 145 | 41.4 |
| Telangiectasia | 18 | 5.1 |
| Cutis marmorata | 9 | 2.6 |
| Generalized erythema | 6 | 1.7 |
| Childhood hemangioma | 3 | 0.8 |
| Pigment | ||
| Genital hyperpigmentation | 39 | 11.1 |
| Mongolian spots | 32 | 9.1 |
| Melanocytic nevus | 2 | 0.8 |
| Café au leite spots | 1 | 0.3 |
| Total | 1,028 | |
Distribution of neonatal dermatoses by category according to parity and delivery method.
| Dermatosis | Parity | % | p-value | Delivery method | % | p-value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Multiparous n=217 | % |
Primiparous n=133 |
Vaginal n=260 | % |
Cesarean n=90 | |||||
| General | ||||||||||
| Sebaceous hyperplasia | 144 | 66.3 | 89 | 66.9 | 1 | 179 | 68.8 | 54 | 60 | 0.92 |
| Physiological flaking | 88 | 40.5 | 52 | 39 | 0.91 | 104 | 40 | 36 | 40 | 1 |
| Fluff | 84 | 38.7 | 65 | 48.8 | 0.27 | 109 | 41.9 | 31 | 34.4 | 0.42 |
| Vernix caseosa | 51 | 23.5 | 40 | 30 | 0.33 | 73 | 28 | 18 | 20 | 0.27 |
| Crystalline miliaria | 52 | 23.9 | 37 | 27.8 | 0.54 | 67 | 25.7 | 22 | 24.4 | 0.89 |
| Toxic erythema | 13 | 5.9 | 5 | 3.75 | 0.46 | 11 | 4.2 | 7 | 7.7 | 0.27 |
| Local | ||||||||||
| Diaper erythema | 8 | 3.6 | 11 | 8.2 | 0.09 | 12 | 4.6 | 7 | 7.7 | 0.29 |
| Seborrheic dermatitis | 1 | 0.4 | 0 | 0 | 1 | 0 | 0 | 1 | 1.1 | 0.25 |
| Vascular | ||||||||||
| Salmon patches | 62 | 28.5 | 83 | 62.4 | <0.001 | 107 | 41.1 | 38 | 42.2 | 0.91 |
| Cutis marmorata | 4 | 1.8 | 5 | 3.7 | 0.31 | 7 | 2.6 | 2 | 2.2 | 1 |
| Generalized erythema | 1 | 0.4 | 5 | 3.7 | 0.034 | 4 | 1.5 | 2 | 2.2 | 0 |
| Pigment | ||||||||||
| Genital hyperpigmentation | 22 | 10.1 | 17 | 12.7 | 0.60 | 33 | 12.6 | 6 | 6.6 | 0.17 |
| Mongolian spots | 13 | 5.9 | 19 | 14.2 | 0.023 | 26 | 10 | 6 | 6.6 | 0.40 |
Distribution of dermatoses according to anatomical regions.
| Dermatosis | Total | Front n=492 | % | Back n=135 | % | LL and LLF n=232 | % | UL and ULF n=92 | % | Torso n=51 | % | Genitals n=8 | % | LBS n=29 | % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sebaceous Hyperplasia | 233 | 233 | 47.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Physiological flaking | 194 | 23 | 4.6 | 4 | 2.9 | 97 | 41.8 | 29 | 31.5 | 3 | 5.8 | 0 | 0 | 0 | 0 |
| Fluff | 196 | 11 | 2.2 | 108 | 80 | 45 | 19.3 | 42 | 45.6 | 1 | 1.9 | 0 | 0 | 0 | 0 |
| Vernix caseous | 106 | 10 | 2 | 1 | 0.7 | 44 | 18.9 | 10 | 10.8 | 30 | 58.8 | 8 | 100 | 0 | 0 |
| Crystalline miliaria | 120 | 53 | 10.7 | 7 | 5.1 | 20 | 8.6 | 1 | 1 | 9 | 17.6 | 0 | 0 | 0 | 0 |
| Toxic erythema | 35 | 11 | 2.2 | 4 | 2.9 | 10 | 4.3 | 1 | 1 | 2 | 3.9 | 0 | 0 | 0 | 0 |
| Salmon patches | 145 | 145 | 29.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cutis marmorata | 9 | 0 | 0 | 1 | 0.7 | 6 | 2.5 | 2 | 2.1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Generalized erythema | 36 | 6 | 1.2 | 6 | 4.4 | 6 | 2.5 | 6 | 6.5 | 6 | 11.7 | 0 | 0 | 0 | 0 |
| Mongolian spots | 38 | 0 | 0 | 4 | 2.9 | 4 | 1.7 | 1 | 1 | 0 | 0 | 0 | 0 | 29 | 100 |
LL: lower limb; LLF: lower limb fold; UL: upper limb; ULF: upper limb fold; LBS: lumbosacral.
Significant associations between the dermatoses and obstetrical, puerperial and neonatal variables.
| Dermatosis | Obstetric profile | OR (p-value) | Puerperal profile | OR (p-value) | Neonatal profile | OR (p-value) | Dermatologic profile | OR (p-value) |
|---|---|---|---|---|---|---|---|---|
| Salmon patches | Primiparous | 21.8 (p<0.001) | ||||||
| Physiological flaking | Cesarean birth | 16,7 (p=0.03) | IG>40 weeks | 0.6 (p=0.054) | ||||
| Genital hyperpigmentation | Non-white | 2,1 (p=0.03) | Masculine | 7.2 (p<0.001) | ||||
| Mongolian spots | Non-white | 3,9 (p<0.001) | ||||||
| Vernix caseous | Feminine | 1,0 (p=0.034) | No flaking | 1.9 (p<0.001) |
OR: Odds Ratio; GI: gestational age.